Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients

Presently, there is inconclusive evidence regarding the most effective treatment for idiopathic nonhistaminergic acquired angioedema (InH-AAE). Omalizumab may, however, prove to be a promising option. This case report describes two patients who presented with recurrent angioedema attacks, which was...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Reports Immunol
Autors principals: Brunetta, Enrico, Shiffer, Dana, Folci, Marco, Achenza, Maria I. S., Puggioni, Francesca, Heffler, Enrico, Furlan, Raffaello, Canonica, Giorgio W.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6081528/
https://ncbi.nlm.nih.gov/pubmed/30140474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8067610
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars